Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients

NCT04083612 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Ghent

Collaborators